CBDNewsBreaks – Jupiter Wellness Inc. (NASDAQ: JUPW) Initiates Exploratory Clinical Trial for Treatment of Herpes
Jupiter Wellness (NASDAQ: JUPW), a leading developer of cannabidiol (“CBD”)-based medical therapeutics and wellness products, has initiated a clinical study evaluating the treatment of herpes labialis (cold sores) for its prescription topical cream candidate JW-100. The company believes this trial may be the first to analyze the efficacy of a combination CBD-aspartame product in the treatment of herpes labialis. JUPW’s topical cream, JW-100, features a dual mechanism of action and relief combined with CBD's potential ability to induce apoptosis in epithelial cells infected with Kaposi sarcoma-associated herpes virus, with aspartame's analgesic and anti-inflammatory properties. The study will include 40 patients…